Cantutay, Marvin A.

HRN: 28-99-20  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2026
CEFTRIAXONE 1G (VIAL)
05/12/2026
05/19/2026
IV
2g
OD
Multiple Abrasions Sec To RCI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines